https://www.selleckchem.com/pr....oducts/Gefitinib.htm
5±22.1 vs. 54.3±23.0 points, p=0.006; and role limitations due to physical health 31.2±36.8 vs. 20.6±31.8 points, p=0.024) when compared to those treated with CABG (n=87). Following CR, patients treated with PCI showed significantly smaller improvements in depression (-0.4±3.1 vs. -1.3±2.7 points, p=0.036) and mental HR-QoL (mental component summary 2.4±10.8 vs. 5.7±10.7 points, p=0.02 when compared to those treated with CABG. Novelty •Patients with coronary artery disease treated with PCI have smaller functional limitations but sim